Status:
COMPLETED
Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
Funding: Stichting Internationaal Parkinson Fonds, The Netherlands
Conditions:
Parkinson's Disease
Parkinsonian Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to determine the sensitivity and specificity of transcranial duplex scanning (TCD) and single photon emission computer tomography (SPECT) in patients suspected of having Id...
Detailed Description
PD is a progressive neurodegenerative illness that affects about 50.000 people in the Netherlands. Diagnosis is based on clinical criteria. However, purely on clinical grounds, especially in the early...
Eligibility Criteria
Inclusion
- Patients with unclear parkinsonism at the outpatient clinic
Exclusion
- Known diagnosis at presentation
- Life expectation of less than two years because of a non neurological disease
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 15 2012
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT00368199
Start Date
September 1 2006
End Date
September 15 2012
Last Update
February 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Center
Maastricht, PO Box 5800, Netherlands, 6202 AZ